ARTICLE | Emerging Company Profile
Generate: applying machine learning to protein design
How Generate Biomedicines is using machine learning to guide therapeutic protein design
September 10, 2020 10:03 AM UTC
Generate Biomedicines Inc., the latest company to emerge from Flagship Pioneering, has a machine learning platform for creating new biologic therapies that should sidestep the trial and error process used to uncover most protein drugs.
The company emerged from stealth on Thursday with over $50 million in funding from Flagship and evidence that its platform can design proteins spanning a range of therapeutic applications and modalities. ...